{
  "meta": {
    "timestamp": "2025-01-06T12:55:51.988233",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "10X Genomics Inc",
      "symbol": "TXG",
      "analysis": {
        "historical": {
          "risk_score": 60,
          "key_risks": [
            "Intellectual Property Litigation",
            "Regulatory and Compliance Challenges",
            "Supply Chain Vulnerabilities",
            "Competitive Pressures",
            "Insider Ownership and Institutional Influence"
          ],
          "controversies": [
            "Ongoing patent disputes with competitors",
            "Legal battles impacting market share and revenue"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Data privacy and ethical handling of genomic data"
          ],
          "governance_issues": [
            "Low insider ownership and high institutional influence"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "10x Genomics defeats startup's attempt to end gene-analysis patent case ...",
              "snippet": "Genomics startup Parse Biosciences lost its bid to dismiss a patent-infringement lawsuit brought by rival 10x Genomics and Stanford University on Thursday, when a Delaware federal court denied ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206133+00:00",
              "published_date": null,
              "source_hash": "f148fb291f2fb04ba821731aad251a91"
            },
            {
              "url": "",
              "title": "Vizgen Announces Significant Win in Ongoing Patent Litigation Against ...",
              "snippet": "U.S. District Court grants Vizgen motion to expand antitrust case against 10x and Harvard based on newly discovered evidence. CAMBRIDGE, Mass. May 6, 2024, Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has achieved a significant victory in its ongoing legal battle with 10x Genomics and Harvard University.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206244+00:00",
              "published_date": null,
              "source_hash": "6def2fa3282f5165203cc9c9b8729b40"
            },
            {
              "url": "",
              "title": "Open Letter to Customers and Researchers in Ongoing Litigation Against ...",
              "snippet": "The invalidity of the patents from Dr. George Church's lab licensed by Harvard to 10X Genomics. Vizgen's defenses that neither Harvard nor 10x Genomics can assert their patents against Vizgen, regardless of any arguments Harvard or 10x Genomics raise about the patents' validity or infringement",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206263+00:00",
              "published_date": null,
              "source_hash": "d838cdb07afd56ad757f3e271a36db44"
            },
            {
              "url": "",
              "title": "10x, Harvard must face antitrust claims in gene-analysis patent cases",
              "snippet": "The cases are 10x Genomics Inc v. NanoString Technologies Inc, U.S. District Court for the District of Delaware, No. 1:22-cv-00261 and 10x Genomics Inc v. Vizgen Inc, U.S. District Court for the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206278+00:00",
              "published_date": null,
              "source_hash": "35f1da7d97a8f21563bbdbb414bb7097"
            },
            {
              "url": "",
              "title": "10X Genomics, Inc. v. Vizgen, Inc. - Casetext",
              "snippet": "This suit arises out of a dispute among two biotechnology companies, 10x Genomics, Inc. (10x) and Vizgen, Inc. (Vizgen), as well as the President and Fellows of Harvard College (Harvard), which owns certain patents that are licensed to 10x or Vizgen. 10x has sued Vizgen for patent infringement, and Vizgen has asserted counterclaims, including a ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206291+00:00",
              "published_date": null,
              "source_hash": "b19d7aad3828e92877abf2a1d05ffcfe"
            },
            {
              "url": "",
              "title": "Vizgen's Antitrust Claims Tossed From 10x, Harvard Patent Suit",
              "snippet": "Vizgen Inc. failed to prove 10x Genomics Inc. unlawfully conspired with Harvard College to monopolize the gene-mapping technology market or used predatory pricing to harm competition, a federal judge ruled, though key aspects of several Vizgen counterclaims will proceed to trial.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404769+00:00",
              "published_date": null,
              "source_hash": "ab653ccd195753a33b446ce3e4bc4d81"
            },
            {
              "url": "",
              "title": "Vizgen Loses Antitrust Claims Against 10x In Biotech IP Fight",
              "snippet": "Law360 (January 3, 2025, 9:46 PM EST) -- A Delaware federal court on Friday dropped Harvard's business partners at 10x Genomics Inc. out of some of the antitrust counterclaims by a rival biotech ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206319+00:00",
              "published_date": null,
              "source_hash": "31719af1e8d5fffb979c4482dd25cdc4"
            },
            {
              "url": "",
              "title": "10x Genomics sues rival Curio over gene-sequencing technology",
              "snippet": "Biotech company 10x Genomics has sued competitor Curio Bioscience in Delaware federal court over allegations that Curio infringed its patents related to genetic analysis, adding to a web of patent ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206330+00:00",
              "published_date": null,
              "source_hash": "162f8603296c542cbf275b756e04d730"
            },
            {
              "url": "",
              "title": "10X GENOMICS INC PRESIDENT AND FELLOWS OF HARVARD COLLEGE v. VIZGEN INC ...",
              "snippet": "10x Genomics, Inc. and the President and Fellows of Harvard College have sued Vizgen, Inc., a biotechnology company, for patent infringement. ... CV 15-723-RGA, 2016 WL 1464545, at *3 (D. Del. Apr. 13, 2016)). In Hynix, the court held that patent litigation was \"causally connected\" because \"a patent 'ambush' or 'hold-up' is ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206341+00:00",
              "published_date": null,
              "source_hash": "6de66683d0d7a901da55d20a7b0b7ea4"
            },
            {
              "url": "",
              "title": "10X Genomics, Inc. v. Brucker Spatial Biology, Inc. - Casetext",
              "snippet": "Read 10X Genomics, Inc. v. Brucker Spatial Biology, Inc., 21 C 653, see flags on bad law, and search Casetext's comprehensive legal database ... '917 Patent at 2:33-36. 10x brought this lawsuit against NanoString, contending that NanoString's GeoMX products infringed upon 10x's patents. Throughout this litigation, NanoString has taken the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:26.206354+00:00",
              "published_date": null,
              "source_hash": "2582ad2f7ebbfc5b6998a6aa5bc5ae14"
            },
            {
              "url": "",
              "title": "Court grants 10x Genomics' motion in part in patent suit against NanoString",
              "snippet": "In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: \"10x Genomics (TXG), Inc. and",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:36.676002+00:00",
              "published_date": "2024-12-23T15:20:00+00:00",
              "source_hash": "21d562fc574194470d4073644d243591"
            },
            {
              "url": "",
              "title": "U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products",
              "snippet": "Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR),",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:28.730147+00:00",
              "published_date": "2024-12-23T21:05:00+00:00",
              "source_hash": "6cd905db3082642ad9029eba6ffb4a50"
            },
            {
              "url": "",
              "title": "10x Genomics secures permanent injunction in Bruker patent infringement lawsuit",
              "snippet": "Genomics (TXG) announced it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:28.730178+00:00",
              "published_date": "2024-12-23T21:10:00+00:00",
              "source_hash": "ce58bfe5caff043e85eb34e5fcb44c0f"
            },
            {
              "url": "",
              "title": "Bruker to Seek Injunction, Appeal After Court Sides with 10x Genomics in Patent Dispute",
              "snippet": "Todd Garland, president of Bruker spatial biology division, said the company expects to promptly seek a stay of any injunction that is finally ordered in the case involving NanoString's GeoMx products.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:28.730202+00:00",
              "published_date": "2024-12-24T15:19:00+00:00",
              "source_hash": "4a83c6ba52769909436afa765931ab1a"
            },
            {
              "url": "",
              "title": "10x Genomics stock slides amid German patent court ruling",
              "snippet": "Shares of 10x Genomics (NASDAQ:TXG ... filed for Chapter 11 bankruptcy protection in February amid ongoing patent litigation with 10xGenomics over its CosMx and GeoMx products.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc patent litigation",
              "retrieved_at": "2025-01-06T19:55:28.730235+00:00",
              "published_date": "2024-05-07T19:03:00+00:00",
              "source_hash": "f1875b8eb837c26abf19860e2f2c7bb6"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "10X GENOMICS, INC. AUDIT COMMITTEE CHARTER I. PURPOSE The Audit Committee (the \"Committee\") shall: ... regulatory, legal or other conditions. The Committee shall also carry out any other responsibilities and duties delegated ... issues arising as to the adequacy of the Company's internal controls, any actions taken in light of material ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619052+00:00",
              "published_date": null,
              "source_hash": "865e20cc15ecbea0ed829c42b087c0b0"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "10X GENOMICS, INC. CORPORATE GOVERNANCE GUIDELINES INTRODUCTION The Board of Directors (the \"Board\") of 10x Genomics, Inc. (the \"Company\") has adopted these corporate governance guidelines, which describe the principles and practices that the Board will follow in carrying out its responsibilities.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619131+00:00",
              "published_date": null,
              "source_hash": "289df843110d55e58db169a7795758c6"
            },
            {
              "url": "",
              "title": "10x Genomics, Inc. - SEC.gov",
              "snippet": "10x Genomics, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware : 3826 : ... regulatory or legal developments in the United States and other countries; ... To achieve compliance with SOX Section 404 within the prescribed period, we are engaged in a process to document and evaluate our internal control over financial reporting ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619146+00:00",
              "published_date": null,
              "source_hash": "29984315fe86dbda2c9fa55362e439aa"
            },
            {
              "url": "",
              "title": "Bio-Rad Laboratories, Inc. - Bio-Rad and 10x Genomics Announce ...",
              "snippet": "The settlement includes a global patent cross-license for patents held by both Bio-Rad and 10x Genomics, resolving outstanding issues in the field of single-cell genomics. In addition to past and future royalties, Bio-Rad receives broad freedom-to-operate in the single-cell market and maintains exclusivity to its microwell single-cell ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619158+00:00",
              "published_date": null,
              "source_hash": "d07431ca8d194972f5162bee7c4d9304"
            },
            {
              "url": "",
              "title": "Legal Notices - 10x Genomics",
              "snippet": "3.3 Regulatory Compliance. Buyer acknowledges that the Products do not have United States Food and Drug Administration (\"FDA\") or equivalent non-U.S. regulatory agency approval (\"Regulatory Approval\"). ... 10x Genomics, Inc. (10x Genomics) owns a number of different trademarks and service marks, including words, logos, icons, and its ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619170+00:00",
              "published_date": null,
              "source_hash": "2cc6041af36008f5038ddd91e773f877"
            },
            {
              "url": "",
              "title": "Supplier Code of Conduct - 10x Genomics",
              "snippet": "Ethics and Compliance. Compliance with Laws and Regulations: Supplier shall comply with all applicable laws, legal regulations and guidelines, as well as all obligations in any contracts with 10x. Anti-corruption: Supplier shall not offer or accept any form of bribery, corruption, extortion, or embezzlement. Supplier shall comply fully with the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619180+00:00",
              "published_date": null,
              "source_hash": "abdf026620eee3aa7359e472c4f2d347"
            },
            {
              "url": "",
              "title": "10x Genomics, Inc. - EDGAR Online",
              "snippet": "The material in this report is not \"soliciting material,\" is not be deemed \"filed\" with the SEC, and is not to be incorporated by reference into any filing made by 10x Genomics, Inc. (the \"Company\") under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619190+00:00",
              "published_date": null,
              "source_hash": "f4652519206e24907e1245e9982e0b14"
            },
            {
              "url": "",
              "title": "Open Letter to Customers and Researchers in Ongoing Litigation Against ...",
              "snippet": "10x Genomics' conduct in interfering with Vizgen's contracts with customers; The invalidity of the patents from Dr. George Church's lab licensed by Harvard to 10X Genomics. Vizgen's defenses that neither Harvard nor 10x Genomics can assert their patents against Vizgen, regardless of any arguments Harvard or 10x Genomics raise about the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619200+00:00",
              "published_date": null,
              "source_hash": "66fa5e71538d023eff7a4db072611b82"
            },
            {
              "url": "",
              "title": "10X Genomics, Inc. ESG Risk Rating - Sustainalytics",
              "snippet": "10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:30.619211+00:00",
              "published_date": null,
              "source_hash": "c3ca2621fe84c5e59c7ca53595f95239"
            },
            {
              "url": "",
              "title": "U.S. District Court Awards 10x Genomics Permanent Injunction in Patent ...",
              "snippet": "The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404783+00:00",
              "published_date": null,
              "source_hash": "7f74050161585b700509a252115575b0"
            },
            {
              "url": "",
              "title": "The TXG Conundrum: Why 10X Genomics Inc's Stock Is Making Headlines Again",
              "snippet": "Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company's success and shareholder interests. Currently, insiders own just 17.61% of 10X Genomics Inc (TXG)'s shares, while financial institutions hold 78.79%.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:36.675870+00:00",
              "published_date": "2025-01-04T13:13:00+00:00",
              "source_hash": "1e9dade601a9913c1ea690acbbc846ff"
            },
            {
              "url": "",
              "title": "Court grants 10x Genomics' motion in part in patent suit against NanoString",
              "snippet": "In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: \"10x Genomics (TXG), Inc. and Prognosys Biosciences, Inc. sued NanoString Technologies ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:32.692443+00:00",
              "published_date": "2024-12-23T15:20:00+00:00",
              "source_hash": "cc387082a81556098cb6021b82476715"
            },
            {
              "url": "",
              "title": "The 10X Genomics Inc Enigma: What's Causing the Wild Swings in TXG Stock?",
              "snippet": "Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company's success and shareholder interests. Currently, insiders own just 17.60% of 10X Genomics Inc (TXG)'s shares, while financial institutions hold 78.78%.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:36.676051+00:00",
              "published_date": "2024-12-25T20:37:00+00:00",
              "source_hash": "e0aab053578f46523b6a1bcc5dc2ef0e"
            },
            {
              "url": "",
              "title": "US District Court awards 10x Genomics permanent injunction in patent infringement lawsuit against Bruker Corporation's GeoMx products",
              "snippet": "10x Genomics, Inc., a leader in single cell and spatial biology, announced it had secured a permanent injunction in the US District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation, which acquired the product line ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "10X Genomics Inc 10X Genomics Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:55:32.692497+00:00",
              "published_date": "2024-12-27T17:00:00+00:00",
              "source_hash": "12d797299bb38b5c47d35c7c24a8734d"
            },
            {
              "url": "",
              "title": "10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now",
              "snippet": "In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:36.676026+00:00",
              "published_date": "2024-11-20T00:40:00+00:00",
              "source_hash": "6fcdbebf37bd768f25ed8923e59cc223"
            },
            {
              "url": "",
              "title": "Privacy Policy - 10x Genomics",
              "snippet": "10x Genomics, Inc. Name or title of data privacy manager: Eunice Lau: Email address: privacy@10xgenomics.com: Postal address: 10x Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton, CA 94588-3260: Telephone number (925) 401-7300",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404721+00:00",
              "published_date": null,
              "source_hash": "3a51cd3000b89992357fc34ad907c697"
            },
            {
              "url": "",
              "title": "Product Privacy Notice - 10x Genomics",
              "snippet": "The 10x Genomics Group (\"10x\", \"we\", \"us\" or \"our\") is committed to the responsible handling and security of personal data and all information entrusted to us. We will process personal data only in accordance with applicable data protection laws, specifically the European Union (EU) General Data Protection Regulation (GDPR).",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404753+00:00",
              "published_date": null,
              "source_hash": "7b4483537282ee24c6edb3cb2efef6b2"
            },
            {
              "url": "",
              "title": " 10x Genomics Security Overview",
              "snippet": "Technical Note 10x Genomics Security Overview CG000753 Rev A 10xgenomics.com 2 The 10x Genomics Cloud Instrument Service's security infrastructure reflects our dedication to safely advancing research while earning your trust in our data protection and privacy measures. 10x Genomics Instruments The Chromium X/iX , Visium CytAssist, and",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404762+00:00",
              "published_date": null,
              "source_hash": "8a22659421f017f83e62d219bc0d7a08"
            },
            {
              "url": "",
              "title": "Open Letter to Customers and Researchers in Ongoing Litigation Against ...",
              "snippet": "10x Genomics' conduct in interfering with Vizgen's contracts with customers The invalidity of the patents from Dr. George Church's lab licensed by Harvard to 10X Genomics. Vizgen's defenses that neither Harvard nor 10x Genomics can assert their patents against Vizgen, regardless of any arguments Harvard or 10x Genomics raise about the ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404776+00:00",
              "published_date": null,
              "source_hash": "fe07e04c41f54f26cf2b01681236af59"
            },
            {
              "url": "",
              "title": "Ransomware strikes 10x Genomics, biotech firm researching possible ...",
              "snippet": "In a financial disclosure form filed to the U.S. Securities and Exchange Commission Wednesday, 10x Genomics Inc. said it experienced an attempted ransomware attack that also involved the theft of company data. The firm restored normal operations \"with no material day-to-day impact,\" and said it is working with law enforcement to investigate ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404789+00:00",
              "published_date": null,
              "source_hash": "e3b4971c3266e5c97f968445ee95a612"
            },
            {
              "url": "",
              "title": "10X Genomics, Inc. v. Brucker Spatial Biology, Inc. - Casetext",
              "snippet": "Bio-Rad Lab'ys, Inc. v. 10X Genomics Inc., 967 F.3d 1353, 1379 (Fed. Cir. 2020) (internal quotation marks omitted). NanoString also argues, and some customer declarations support, that NanoString's customers do not find 10x's Visium products to be a viable substitute to GeoMx products.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404796+00:00",
              "published_date": null,
              "source_hash": "5a8a0b87ee0c1e14b2495b41b0a2be50"
            },
            {
              "url": "",
              "title": "10x Genomics sues rival Curio over gene-sequencing technology",
              "snippet": "The case is 10x Genomics Inc v. Curio Bioscience Inc, U.S. District Court for the District of Delaware, No. 1:23-cv-01375. For 10x: Matthew Powers, Paul Ehrlich, Stefani Smith and Robert Gerrity ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404803+00:00",
              "published_date": null,
              "source_hash": "c5be8f55112c8012fbacd433ff6dc4ae"
            },
            {
              "url": "",
              "title": "Court grants 10x Genomics' motion in part in patent suit ... - Nasdaq",
              "snippet": "In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: \"10x Genomics , Inc. and Prognosys Biosciences, Inc. sued NanoString Technologies, Inc.1 ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:34.404809+00:00",
              "published_date": null,
              "source_hash": "c249cfa0f05e4c73836cec62164f1736"
            },
            {
              "url": "",
              "title": "10x Genomics",
              "snippet": "10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "10X Genomics Inc 10X Genomics Inc data privacy concerns",
              "retrieved_at": "2025-01-06T19:55:36.675973+00:00",
              "published_date": "2024-12-27T21:00:00+00:00",
              "source_hash": "df3083758fc1481a812e70c7cf067b57"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "10X Genomics Inc patent litigation",
              "rationale": "Investigate ongoing or past legal disputes related to intellectual property",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "10X Genomics Inc regulatory compliance issues",
              "rationale": "Examine challenges in adhering to global regulatory standards",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "10X Genomics Inc data privacy concerns",
              "rationale": "Assess potential controversies related to the handling of sensitive genomic data",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T12:55:51.988238",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}